For people seeking additional approaches to control their Condition 2 glucose, Mounjaro provides a promising advance. This drug, created by Lilly, works by affecting two substances: GLP-1 and GIP, which play important roles in regulating sugar amounts. Unlike several previous treatments, Mounjaro demonstrates promise for significant body decrease i